CytexOrtho key facts
as of Oct 2026- Developer of regenerative medical technologies designed to treat early joint disease.
- CytexOrtho is valued at approximately $18.6M as of Oct 2026 (last reported valuation).
- It has raised $4.4M; the latest was Later Stage VC in Jun 2026.
- Notable investors include US National Science Foundation, MedTech Innovator, Liquid 2 Ventures, NC Idea, Heinz Ventures — 9 tracked in total.
- Status: Privately Held (backing).
CytexOrtho's last reported valuation, Jan 2023. Nothing priced has surfaced since.
- ·Watch CytexOrtho: the Monday email on marks, rounds and moves
CytexOrtho funding rounds
No funding rounds for CytexOrtho are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CytexOrtho valuation
CytexOrtho's last reported valuation was $18.6 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.
CytexOrtho investors
9 investors are on record for CytexOrtho, including US National Science Foundation, MedTech Innovator, Liquid 2 Ventures and NC Idea.
About CytexOrtho
Developer of regenerative medical technologies designed to treat early joint disease. The company focuses on restoring rather than replacing joints, enabling patients with chronic pain and limited mobility to achieve longer-lasting relief beyond symptom management.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2006
- Employees
- 10
- Website
- cytexortho.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.